Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma

Published:2012-03-18 Issue:5 Volume:55 Page:1443-1452
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Kim Soo Mi,Leem Sun-Hee,Chu In-Sun,Park Yun-Yong,Kim Sang Cheol,Kim Sang-Bae,Park Eun Sung,Lim Jae Yun,Heo Jeonghoon,Kim Yoon Jun,Kim Dae-Ghon,Kaseb Ahmed,Park Young Nyun,Wang Xin Wei,Thorgeirsson Snorri S.,Lee Ju-Seog

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.24813/fullpdf

Reference35 articles.

1. Estimating the world cancer burden: Globocan 2000;Parkin;Int J Cancer,2001

2. HCC surveillance: who is the target population?;Bruix;HEPATOLOGY,2003

3. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients;Okuda;Cancer,1985

4. Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patients;Calvet;HEPATOLOGY,1990

5. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators;CLIP investigators;HEPATOLOGY,1998

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HN1-mediated activation of lipogenesis through Akt-SREBP signaling promotes hepatocellular carcinoma cell proliferation and metastasis;Cancer Gene Therapy;2024-09-09

2. Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females;2024-07-18

3. Sex differences in bile acid homeostasis and excretion underlie the disparity in liver cancer incidence between males and females;2024-07-18

4. A new prognostic model for accurate assessment of hepatocellular carcinoma risk using RNA editing data and unsupervised machine learning;Neurocomputing;2024-05

5. Precision Oncology in Hepatopancreatobiliary Cancer Surgery;Surgical Oncology Clinics of North America;2024-04